BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: geewiz who wrote (407)	11/11/1999 9:35:00 AM
From: geewiz	of 534

The market segment represented on the chart in previous post troubles me because it fails to show overlap of delivery vectors; for example, treatment of an oncology drug in an adenvirus package with a gene gun. Drugs employing a dead viral vector are not excluded from applications of our products. Additional market acceptance is encouraging; SOURCE: Bioject Medical Technologies, Inc. Bioject Receives CE Mark For Needle-Free Jet Injection Systems PORTLAND, Ore., Nov. 11 /PRNewswire/ -- Bioject Medical Technologies, Inc. (Nasdaq: BJCT - news), the leading developer and manufacturer of jet injection systems for needle-free drug delivery, today announced that it has received CE Mark certification for the company's needle-free jet injection systems. The CE Mark indicates that Bioject's injection systems may be sold throughout the European Union and that the company's products comply with applicable safety and quality standards. biz.yahoo.com Also a great source of information on gene therapy at Vanderbilt; mc.vanderbilt.edu later, art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next